1. Home
  2. CING vs DPRO Comparison

CING vs DPRO Comparison

Compare CING & DPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CING
  • DPRO
  • Stock Information
  • Founded
  • CING 2012
  • DPRO 1998
  • Country
  • CING United States
  • DPRO Canada
  • Employees
  • CING N/A
  • DPRO N/A
  • Industry
  • CING Biotechnology: Pharmaceutical Preparations
  • DPRO Aerospace
  • Sector
  • CING Health Care
  • DPRO Industrials
  • Exchange
  • CING Nasdaq
  • DPRO Nasdaq
  • Market Cap
  • CING 13.1M
  • DPRO 13.0M
  • IPO Year
  • CING 2021
  • DPRO N/A
  • Fundamental
  • Price
  • CING $4.36
  • DPRO $2.79
  • Analyst Decision
  • CING Strong Buy
  • DPRO Strong Buy
  • Analyst Count
  • CING 4
  • DPRO 2
  • Target Price
  • CING $30.67
  • DPRO $7.00
  • AVG Volume (30 Days)
  • CING 97.0K
  • DPRO 83.8K
  • Earning Date
  • CING 05-07-2025
  • DPRO 05-13-2025
  • Dividend Yield
  • CING N/A
  • DPRO N/A
  • EPS Growth
  • CING N/A
  • DPRO N/A
  • EPS
  • CING N/A
  • DPRO N/A
  • Revenue
  • CING N/A
  • DPRO $4,559,961.00
  • Revenue This Year
  • CING N/A
  • DPRO $146.64
  • Revenue Next Year
  • CING N/A
  • DPRO $71.45
  • P/E Ratio
  • CING N/A
  • DPRO N/A
  • Revenue Growth
  • CING N/A
  • DPRO 0.10
  • 52 Week Low
  • CING $1.80
  • DPRO $1.55
  • 52 Week High
  • CING $20.83
  • DPRO $9.13
  • Technical
  • Relative Strength Index (RSI)
  • CING 57.77
  • DPRO 53.12
  • Support Level
  • CING $4.03
  • DPRO $2.52
  • Resistance Level
  • CING $4.44
  • DPRO $2.75
  • Average True Range (ATR)
  • CING 0.29
  • DPRO 0.24
  • MACD
  • CING 0.04
  • DPRO 0.04
  • Stochastic Oscillator
  • CING 74.38
  • DPRO 90.70

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

About DPRO Draganfly Inc.

Draganfly Inc is a Canada based company. It is engaged in the provision of engineering services and the manufacture of commercial unmanned vehicle systems and software. The company operates in Canada, the United States, and Internationally. The three segments are Drones, Vital (Vital Intelligence), and Corporate. The Drones segment derives its revenue from products and services related to the sale of unmanned aerial vehicles (UAV). The Vital segment derives its revenue from the sale of products that measure vitals to help detect symptoms from large groups of people from a distance. The Corporate segment includes all costs not directly associated with the Drone and Vital segments. It generates majority of its revenue from Drones segment.

Share on Social Networks: